Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF), a medical research company in the psychedelics space, recently announced that it has established direct billing practices for its ketamine treatment at specialized mental health clinics in Canada that serve Canadian military veterans.
Clinics from the Canadian Rapid Treatment Center of Excellence Inc., a wholly-owned subsidiary of Braxia with locations in Mississauga, Toronto, Ottawa and Montreal will
establish direct billing practices with health insurance provider Medavie Blue Cross for qualifying Canadian military veterans.
The insurance provider will cover 100% of oral, nasal spray and intravenous ketamine treatments, plus travel costs.
Why It Matters
Ketamine is a dissociative drug approved as an anesthetic in the 1960s. Today, it is used …